Improved Insulin Sensitivity: It helps the bodys cells respond more effectively to insulin, which is particularly beneficial for individuals with insulin resistance, a hallmark of Type 2 diabetes
Recently, another Italian real-world retrospective study showed the efficacy and safety of oral semaglutide in a T2DM population, that was older compared with the PIONEER trials, similarly to the population described in our study [28]
Acomete principalmente indivduos debilitados, imunocomprometidos
[18] In clinical trials of this drug class, individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2) are typically excluded as a precautionary measure
Titration governs tolerability fast 2-week ramp to 15 mg gave 24.5% AE-discontinuation (Frias 2018)
Safety: No therapy-related adverse effects were reported